Zenas Biopharma Inc (NASDAQ: ZBIO) started the day on Wednesday, with a price increase of 24.22% at $25.9, before settling in for the price of $20.85 at the close. Taking a more long-term approach, ZBIO posted a 52-week range of $5.83-$26.25.
Nevertheless, stock’s Earnings Per Share (EPS) this year is 71.19%. This publicly-traded company’s shares outstanding now amounts to $42.09 million, simultaneously with a float of $10.31 million. The organization now has a market capitalization sitting at $1.09 billion. At the time of writing, stock’s 50-day Moving Average stood at $18.39, while the 200-day Moving Average is $11.63.
Zenas Biopharma Inc (ZBIO) Ownership Facts and Figures
Now let’s turn our focus to how large-scale investors are working with this stock of the Biotechnology Industry. Zenas Biopharma Inc’s current insider ownership accounts for 75.52%, in contrast to 35.90% institutional ownership. According to the most recent insider trade that took place on Feb 18 ’25, this organization’s Chief Executive Officer bought 25,000 shares at the rate of 6.67, making the entire transaction reach 166,750 in total value, affecting insider ownership by 266,155. Preceding that transaction, on Feb 07 ’25, Company’s Director bought 10,000 for 7.76, making the whole transaction’s value amount to 77,600. This particular insider is now the holder of 47,000 in total.
Zenas Biopharma Inc (ZBIO) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.17 per share during the current fiscal year.
Zenas Biopharma Inc’s EPS increase for this current 12-month fiscal period is 71.19% and is forecasted to reach -4.33 in the upcoming year.
Zenas Biopharma Inc (NASDAQ: ZBIO) Trading Performance Indicators
Let’s observe the current performance indicators for Zenas Biopharma Inc (ZBIO). It’s Quick Ratio in the last reported quarter now stands at 5.23. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 72.71.
In the same vein, ZBIO’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -4.23, a figure that is expected to reach -0.67 in the next quarter, and analysts are predicting that it will be -4.33 at the market close of one year from today.
Technical Analysis of Zenas Biopharma Inc (ZBIO)
If we take a close look at the recent performances of Zenas Biopharma Inc (NASDAQ: ZBIO), its last 5-days Average volume was 0.42 million that shows progress from its year to date volume of 0.2 million. During the previous 9 days, stock’s Stochastic %D was recorded 73.11% While, its Average True Range was 69.18.
Raw Stochastic average of Zenas Biopharma Inc (ZBIO) in the period of the previous 100 days is set at 96.10%, which indicates a major rise in contrast to 91.70% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 2.42 that was higher than 1.38 volatility it exhibited in the past 100-days period.
